Startup iRhythm Technologies Inc. has raised $17 million to support market expansion, product development and evidence collection for its Zio Patch technology and service that it says could replace the traditional Holter monitor for detecting heart arrhythmias.
The Series E round, announced May 22, was led by Novo A/S, a life sciences investment fund and the parent company of Novo Nordisk AS. Novo A/S will be...